A new kind of gold rush is quietly reshaping drug discovery—and this time, the treasure is not buried in animal facilities or clinical trial databases, but preserved in living human gastrointestinal tissue.   As pharmaceutical pipelines accelerate and regulatory expectations tighten, traditional in vivo models are showing their limits. Animal studies remain costly,...